Loading...

Organigram Global Inc.

OGI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.45
$0.01(1.05%)
U.S. Market opens in NaNh NaNm

Organigram Global Inc. (OGI) Stock Overview

Explore Organigram Global Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap197M
P/E Ratio14.68
EPS (TTM)$0.11
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$1.59
3 Months$1.34
1 Year Target$1.43

OGI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Organigram Global Inc. (OGI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.68 and a market capitalization of 197M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.70%
5-Day Change
-6.77%
1-Month Change
7.84%
3-Month Change
-12.95%
6-Month Change
-17.43%
Year-to-Date (YTD) Change
-13.99%
1-Year Change
24.57%
3-Year Change
-29.17%
5-Year Change
-86.62%
All-Time (Max) Change
-95.37%

Contact Information

https://www.organigram.ca
15063841571
35 English Drive, Moncton, NB, E1E 3X3

Company Facts

1,093 Employees
IPO DateMay 21, 2019
CountryCA
Actively Trading

Frequently Asked Questions